http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7771652-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4e0010b352ea6734302f8d56f9443c5
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-20
filingDate 2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a96d8d4f54e1afab5285cb0f6d909247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a34052db9ac7469c281d54906f2df1b
publicationDate 2010-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7771652-B2
titleOfInvention Combined use of an alkaline earth metal compound and a sterilizing agent to maintain osteoinduction properties of a demineralized bone matrix
abstract A method is disclosed that produces allografts from matrices typically containing demineralized bone matrix (DBM) powder, demineralized bone matrix gel, demineralized bone matrix paste, bone cement, cancellous bone, or cortical bone and mixtures thereof. The matrices are sterilized utilizing supercritical CO 2 in the presence of a sterilizing additive and an entrainer such as an alkaline earth metal compound, preferably CaCO 3 . The resultant allograft materials have a reduced rate of rejection when used in allograft procedures including, bone, cartilage, tendon, and ligament grafting procedures.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8696744-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017112945-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8449607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9649408-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10293064-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8679176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012166538-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8845719-B2
priorityDate 2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7108832-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128375819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15240839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448915161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559254

Total number of triples: 38.